Table 3.
Diagnostic performance
| Methods | Sensitivity | Specificity | Accuracy (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|
| MVI | |||||
| Tumor size | 35.00 (21/61) | 80.00 (92/115) | 64.57 | 47.73 | 70.23 |
| HBsAg | 91.67 (55/60) | 18.26 (21/115) | 43.43 | 36.91 | 80.77 |
| Tumor Number | 28.33 (17/60) | 88.70 (102/115) | 68.00 | 56.67 | 70.34 |
| Capsule | 78.33 (47/60) | 39.13 (45/115) | 52.57 | 40.17 | 77.59 |
| Arterial peritumoral enhancement | 31.67 (19/60) | 96.52 (111/115) | 74.29 | 82.61 | 73.03 |
| Tumor margin | 76.67 (46/60) | 53.04 (61/115) | 61.14 | 46.00 | 81.33 |
| Series connection* | 0.00 (0/60) | 100.00 (115/115) | 65.71 | – | 65.71 |
| Parallel connection# | 100.00 (60/60) | 0.87 (1/115) | 34.86 | 34.48 | 100.00 |
| Grade | |||||
| Tumor Number | 21.26 (27/127) | 93.75 (45/48) | 41.14 | 90.00 | 31.03 |
| Cirrhosis | 31.50 (40/127) | 87.50 (42/48) | 46.86 | 86.96 | 32.56 |
| Capsule | 72.44 (92/127) | 47.92 (23/48) | 65.71 | 78.63 | 39.66 |
| shape | 72.44 (92/127) | 47.92 (23/48) | 65.71 | 78.63 | 39.66 |
| Series connection* | 0.00 (0/127) | 100.00 (48/48) | 27.43 | – | 27.43 |
| Parallel connection# | 100.00 (127/127) | 2.08 (1/48) | 73.14 | 72.99 | 100.00 |